Literature DB >> 11868009

Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study.

Hyun Soo Kim1, Dong Ki Lee, Ho Gak Kim, Jong Jae Park, Sang Heum Park, Jin Hong Kim, Byung Moo Yoo, Im Hwan Roe, Young Soo Moon, Seung Jae Myung.   

Abstract

BACKGROUND: Although placement of a metallic stent is an established therapeutic option for the palliation of patients with malignant biliary obstruction, it remains unclear which stricture-related or stent-related factors influence stent patency.
METHODS: Metallic stents were inserted endoscopically in 68 patients (38 men, 30 women; mean age 70.2 plus minus 8.5 years) with malignant biliary obstruction. Patency rates were prospectively analyzed according to malignant stricture characteristics, including length, morphologic type, and degree of narrowing. Furthermore, patient age, initial serum bilirubin level, length of stent, time to adequate expansion, and the location of the distal end of the stent were evaluated as possible factors affecting the stent patency. Stent patency was assessed by using the survival analysis of the Kaplan-Meier estimation and Cox regression analysis.
RESULTS: Median overall stent patency was 231 days (range 27-379 days) and the overall rate of stent occlusion 41.2% (28/68). The causes of occlusion were tumor ingrowth in 23 patients (33.8%), distal overgrowth in 3 (4.4%), proximal overgrowth in 1 (1.5%), and encrustation with sludge in 1 patient (1.5%). No significant differences in patency rates according to patient age, initial serum bilirubin level, primary tumor type, length and morphologic type of stricture, and length and location of the distal end of the stent were found. Cox regression analysis demonstrated that the degree of narrowing assessed by cannula or guidewire passage and the time to adequate expansion of the stent were independent factors associated with stent patency.
CONCLUSION: Early expansion of the stent and easy passage of larger-caliber instruments through the stricture were favorable factors for long-term patency of the Wallstent.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11868009     DOI: 10.1067/mge.2002.121603

Source DB:  PubMed          Journal:  Gastrointest Endosc        ISSN: 0016-5107            Impact factor:   9.427


  13 in total

1.  Endoscopic management of occluded biliary uncovered metal stents: a multicenter experience.

Authors:  Panagiotis Katsinelos; Athanasios Beltsis; Grigoris Chatzimavroudis; Dimitris Paikos; George Paroutoglou; Dimitris Kapetanos; Sotiris Terzoudis; Georgia Lazaraki; Ioannis Pilpilidis; Kostas Fasoulas; Stefanos Atmatzidis; Christos Zavos; Jannis Kountouras
Journal:  World J Gastroenterol       Date:  2011-01-07       Impact factor: 5.742

2.  Multicenter study evaluating factors for stent patency in patients with malignant biliary strictures: development of a simple score model.

Authors:  Petra G A van Boeckel; Ewout W Steyerberg; Frank P Vleggaar; Marcel J M Groenen; Ben J M Witteman; Bas L A M Weusten; Han Geldof; Adriaan C I T L Tan; Marina J A L Grubben; Jan Nicolai; Peter D Siersema
Journal:  J Gastroenterol       Date:  2011-07-14       Impact factor: 7.527

3.  HDR-192Ir intraluminal brachytherapy in treatment of malignant obstructive jaundice.

Authors:  Yi Chen; Xiao-Lin Wang; Zhi-Ping Yan; Jie-Min Cheng; Jian-Hua Wang; Gao-Quan Gong; Sheng Qian; Jian-Jun Luo; Qing-Xin Liu
Journal:  World J Gastroenterol       Date:  2004-12-01       Impact factor: 5.742

4.  Self-expandable metallic stents for malignant biliary obstruction: efficacy on proximal and distal tumors.

Authors:  Jui-Hao Chen; Cheuk-Kay Sun; Chao-Sheng Liao; Chain-Smoke Chua
Journal:  World J Gastroenterol       Date:  2006-01-07       Impact factor: 5.742

5.  Prognostic relevance of circulating CK19 mRNA in advanced malignant biliary tract diseases.

Authors:  Kawin Leelawat; Siriluck Narong; Wandee Udomchaiprasertkul; Jerasak Wannaprasert; Sa-ard Treepongkaruna; Somboon Subwongcharoen; Tawee Ratanashu-ek
Journal:  World J Gastroenterol       Date:  2012-01-14       Impact factor: 5.742

6.  Efficacy of a metallic stent covered with a paclitaxel-incorporated membrane versus a covered metal stent for malignant biliary obstruction: a prospective comparative study.

Authors:  Sung Ill Jang; Jie-Hyun Kim; Jung Whan You; Kwangwon Rhee; Se Joon Lee; Ho Gak Kim; Jimin Han; Im Hee Shin; Sang-Heum Park; Dong Ki Lee
Journal:  Dig Dis Sci       Date:  2012-11-21       Impact factor: 3.199

7.  Future developments in biliary stenting.

Authors:  Clark D Hair; Divyesh V Sejpal
Journal:  Clin Exp Gastroenterol       Date:  2013-06-24

8.  Efficacy of a Multiplex Paclitaxel Emission Stent Using a Pluronic® Mixture Membrane versus a Covered Metal Stent in Malignant Biliary Obstruction: A Prospective Randomized Comparative Study.

Authors:  Sung Ill Jang; Se Joon Lee; Seok Jeong; Don Haeng Lee; Myung-Hwan Kim; Hong Jin Yoon; Dong Ki Lee
Journal:  Gut Liver       Date:  2017-07-15       Impact factor: 4.519

9.  Predictors for occlusion of the first inserted metallic stent in patients with malignant biliary obstruction.

Authors:  Wandong Hong; Yunfei Zhu; Yanyan Dong; Yanqing Wu; Mengtao Zhou; Haizhen Ni
Journal:  Saudi J Gastroenterol       Date:  2015 Nov-Dec       Impact factor: 2.485

10.  Novel Silicone-Coated 125I Seeds for the Treatment of Extrahepatic Cholangiocarcinoma.

Authors:  Lizhou Lin; Lili Guo; Weixing Zhang; Xiaobo Cai; Dafan Chen; Xinjian Wan
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.